PrognostICate- Study:Prognostication of ICU- and Ventilator- Days Over the Next Years Until 2040
Recruiting
Observational Study
ICU Admission
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Day – 120
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000,000 (estimated)
- Sponsor
- University Hospital of Cologne · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Objective of this retrospective multicenter- study is to forecast Intensive Care Unit (ICU) length of stay (ICULOS) and length of mechanical ventilation (LOMV) in ICU patients of different groups (regarding gender, age group, medical vs surgical admission) worldwide for the next years up to the year of 2040 using statistical forecasting models and historical, national and international ICU dat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients admitted to an ICU between the years 2005-2023
Exclusion Criteria:
* Patients without ICU admission or ICU admission \< 4 hours
Contacts